Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm® 09/2019
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

SPOT ON
Administrative courts block preventive consumer protection

NEW ON THE MARKET
Andexanet alfa (ONDEXXYA) antidote for rivaroxaban and apixaban

THERAPY FROM A CRITICAL VIEWPOINT
Breast cancer with postmenopausal hormone treatment
Ticagrelor or prasugrel in acute coronary syndrome?

IN BRIEF
Fremanezumab (AJOVY) in treatment-refractory migraine
Nitrosamine in all ranitidine preparations?

CURRENT ADR NETWORK REPORT
Itraconazole and hypertension  free article 

SIDE EFFECTS
Trismus with the ADHD drug methylphenidate (RITALIN, generics)
Vaping illness: FDA warns against tetrahydrocannabinol (THC)-containing liquids for e-cigarettes
Liver damage with newer combination drugs against hepatitis C
Life-threatening lung disease with CDK4/6 inhibitors

e a-t ON THE INTERNET
Andexanet alfa (ONDEXXYA) antidote for rivaroxaban and apixaban (long version)
© 2019 arznei-telegramm